Pratt John 4
4 · Pacira Pharmaceuticals, Inc. · Filed Mar 14, 2013
Insider Transaction Report
Form 4
Pratt John
General Manager, San Diego
Transactions
- Exercise/Conversion
Common Stock
2013-03-12$8.73/sh+9,375$81,844→ 9,375 total - Sale
Common Stock
2013-03-12$28.46/sh−9,375$266,813→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-03-12−9,375→ 20,625 totalExercise: $8.73Exp: 2022-01-02→ Common Stock (9,375 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.45 to $28.501, inclusive. The reporting person undertakes to provide to Pacira Pharmaceuticals, Inc., any security holder of Pacira Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
- [F2]The option vested and became exercisable as to 25% of the option shares on January 3, 2013 and vests and becomes exercisable as to the remaining shares in successive equal monthly installments at the end of each month over the subsequent 36 months.